Profound Medical Corp (TSX:PRN)
C$ 10.03 0.03 (0.3%) Market Cap: 301.19 Mil Enterprise Value: 271.15 Mil PE Ratio: 0 PB Ratio: 5.88 GF Score: 68/100

Q1 2021 Profound Medical Corp Earnings Call Transcript

May 12, 2021 / 08:30PM GMT
Release Date Price: C$21.76 (-4.73%)
Operator

Thank you for standing by, and welcome to Profound Medical First Quarter 2021 Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I will now like to hand the conference over to your speaker today, Stephen Kilmer, with Investor Relations.

Stephen Kilmer
Profound Medical Corp. - IR

Thank you. Good afternoon, everyone. Let me start by pointing out that this conference call will include forward-looking statements regarding Profound and its business, which may include, but is not limited to, expectations regarding the efficacy of Profound's technology in the treatment of prostate cancer, BPH, uterine fibroids, palliative pain and osteoid osteoma. Often, but not always, forward-looking statements can be identified by the use of words such as plans, is expected, expects, scheduled, intends, contemplates, anticipates, believes, proposes or variations including negative variations of such words and phrases or state that certain actions, events or results, may, could, would, might or will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot